Cargando…

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma

BACKGROUND: With the highest mortality and metastasis rate, kidney renal clear cell carcinoma (KIRC) is one of the most common urological malignant tumors and not sensitive to chemotherapy and radiotherapy. Immunotherapy, which proves to be effective and a big progression, such as PD-1/PD-L1 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, ZhiXiang, Sun, XinXin, Li, Kun, Zhang, YanYan, Zuo, ShiKai, Li, CanCan, Wan, Shi, Huang, DongMei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822741/ https://www.ncbi.nlm.nih.gov/pubmed/36618968 http://dx.doi.org/10.1155/2022/9010514

Ejemplares similares

Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte‐associated genes
por: Chen, Can, et al.
Publicado: (2022)

Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma
por: Zhou, Qi, et al.
Publicado: (2021)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Paraneoplastic Eosinophilia in Clear Cell Renal Cell Carcinoma
por: Zhou, Wei-Wei, et al.
Publicado: (2015)

CARS as a Prognosis Factor in Clear Cell Renal Cell Carcinoma and Its Association with Tumor Immunity
por: Meng, Quan, et al.
Publicado: (2021)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
por: Meng, Quan, et al.
Publicado: (2021)

5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma
por: Chen, Can, et al.
Publicado: (2022)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

Simultaneous renal clear cell carcinoma and gastrointestinal stromal tumor in one case
por: Wen, Jin, et al.
Publicado: (2013)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

The expression and prognostic value of RNA binding proteins in clear cell renal cell carcinoma
por: Li, Can-Xuan, et al.
Publicado: (2020)

Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients
por: Yao, Jiannan, et al.
Publicado: (2023)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy
por: Chen, Can, et al.
Publicado: (2023)

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
por: Liu, Gang, et al.
Publicado: (2023)

Upregulated Fibulin-1 Increased Endometrial Stromal Cell Viability and Migration by Repressing EFEMP1-Dependent Ferroptosis in Endometriosis
por: Wan, Yiting, et al.
Publicado: (2022)

High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma
por: WEI, CAN, et al.
Publicado: (2013)

Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Lee, Ji Hyun, et al.
Publicado: (2023)

Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma
por: Huang, Wan, et al.
Publicado: (2017)

Construction of an Immune Escape-Related Signature in Clear Cell Renal Cell Carcinoma and Identification of the Relationship between IFNAR1 and Immune Infiltration by Multiple Immunohistochemistry
por: Chang, Kun, et al.
Publicado: (2022)

The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Deng, Lugang, et al.
Publicado: (2021)

Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma
por: Ma, Chuanyu, et al.
Publicado: (2020)

A Contemporary Review of Immune Checkpoint Inhibitors in Advanced Clear Cell Renal Cell Carcinoma
por: Yu, Eun-mi, et al.
Publicado: (2021)

Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma
por: Wu, Ding, et al.
Publicado: (2022)

Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma
por: Wang, Bin, et al.
Publicado: (2022)

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
por: Wei, Shuzhang, et al.
Publicado: (2023)

Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities
por: Zarrabi, Kevin, et al.
Publicado: (2021)

Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe
por: Malicki, Stanisław, et al.
Publicado: (2022)

A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
por: Palma dos Reis, Ana Filipa, et al.
Publicado: (2022)

High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
por: Ma, Wenliang, et al.
Publicado: (2022)

Prognostic Roles of Phosphofructokinase Platelet in Clear Cell Renal Cell Carcinoma and Correlation with Immune Infiltration
por: Liu, Bin, et al.
Publicado: (2021)

Comprehensive Evaluation of the m(6)A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Yu, Mingke, et al.
Publicado: (2022)

Case Report: Successful immune checkpoint inhibitor-based rechallenge in a patient with advanced renal clear cell cancer
por: He, Shengxiu, et al.
Publicado: (2023)

FCGR2A as one novel potential target for poor survival prognosis of clear cell renal cell carcinoma
por: Fu, Taozhu, et al.
Publicado: (2023)

Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma
por: Ebru, Tastekin, et al.
Publicado: (2017)

Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network
por: Xiao, Zhiliang, et al.
Publicado: (2023)

Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023)

A comparison of the prognosis of papillary and clear cell renal cell carcinoma: Evidence from a meta-analysis
por: Deng, Jun, et al.
Publicado: (2019)

Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jupd760sig0b8c6pdo88odd070